J&J | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
AbbVie USD 5.52B 1.73B 2024-12
Abbott USD 6.53B 1.08B 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Baxter International USD 1.76B 344M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Becton, Dickinson and Co. USD 667M 44M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Boston Scientific USD 725M 311M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
CONMED USD 35.48M 11.03M 2025-03
Cooper Companies USD 100.9M 6.7M 2025-01
Dexcom USD 904.9M 298.8M 2025-03
Edwards Lifesciences USD 3.05B 631.2M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Globus Medical USD 784.44M 161.67M 2024-12
Hologic USD 1.43B 352.6M 2025-03
Indivior 372M 53M 2025-03
Insulet USD 820M 133.5M 2024-12
Integra LifeSciences USD 246.38M 31.22M 2024-12
Intuitive Surgical USD 9.1B 268.8M 2025-03
J&J USD 38.47B 32.35B 2025-03
Medtronic USD 1.24B 154M 2025-01
Merck USD 8.63B 4.61B 2025-03
Merit Medical Systems USD 395.53M 18.81M 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Stryker USD 2.32B 1.33B 2025-03
Tandem Diabetes Care USD 53.57M 15.66M 2025-03
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Zimmer Biomet Holdings USD 525.5M 43.5M 2024-12
Zoetis USD 1.98B 275M 2024-12



J&J Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.